Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCrimson Tide Regulatory News (TIDE)

Share Price Information for Crimson Tide (TIDE)

Share Price is delayed by 15 minutes
Get Live Data
87.50    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 5.00 (5.882%)
Market Cap: £5.75m
TIDE Live PriceLast checked at - London Stock Exchange

Intraday Crimson Tide Share Chart

Pharmaceutical Verification Pilot

14 Jul 2016 07:00

RNS Number : 1316E
Crimson Tide PLC
14 July 2016
 

Crimson Tide PLC

 

("Crimson Tide" or the 'Company')

 

Crimson Tide selected for pharmaceutical verification pilot

 

Crimson Tide (TIDE), the AIM-quoted provider of mpro5 - Smart Mobility as a Service, has won a contract for the initial stage of a significant healthcare pilot project in Asia for the serialisation and verification of pharmaceutical products. The pilot project is being implemented under the auspices of the Asia Pacific Economic Cooperation (APEC) Life Sciences Innovation Forum (LSIF), Committee on Trade and Investment (CTI) and Business Advisory Council (ABAC).

 

Selected by a consortium of pharma organisations, the technology platform for the demonstration phase of the pilot project will leverage mpro5 to scan pharmaceutical products, generating an anonymous verification request to the product's manufacturer. The pilot project seeks to demonstrate for the first time the ability to verify serialised pharmaceutical products from various scan locations to source data stored in distributed databases using global data standards. The pilot also seeks to promote harmonisation by demonstrating the ability to use a single or reproducible data gateway in multiple countries.

 

mpro5 provides barcode scanning and cloud-based synchronisation services via Microsoft Azure, renowned for its reliability, scalability and security. This enables real-time information upload, quick verifications and multi-way data request transmittals.

 

Barrie Whipp, Executive Chairman of Crimson Tide, said: "The global impact of drug serialisation and verification cannot be underestimated. I am delighted that we have been chosen to help in this pilot project in Asia, as it opens up significant opportunities in the pharma world."

 

ends

 

For further information:

 

Crimson Tide plc

 

Barrie Whipp 01892 542 444

Steve Goodwin

 

WH Ireland

 

James Joyce /James Bavister 020 7220 1666

Allerton Communications

Peter Curtain 020 3137 2500

peter.curtain@allertoncomms.co.uk 

 

Notes to editors

Founded in 1996 and quoted on AIM since 2006, Crimson Tide plc is the provider of mpro5 - Smart Mobility as a Service (SMaaS). mpro5 is delivered on smartphones, tablets and PDAs, and enables companies to transform their businesses and strengthen their workforces.

Crimson Tide offers a global service, working with some of the world's leading companies, tailoring mpro5 to suit customer needs. Developed over 10 years by its world-class team, mpro5 is the smart choice for organisations large and small that want to improve productivity and save money.

mpro5 is a platform-agnostic mobility suite fully hosted on Microsoft Azure, so customers are quickly up and running and the service is scalable and robust. It is provided on subscription, so clients can immediately see a return on their investment.

mpro5 not only helps people improve their day-to-day working methods while saving employers money, it also saves lives, by enabling haemophilia patients to verify the safety of their medication before use. mpro5 clients come from a diverse range of industries allowing the Company to listen, share and find the best solution for all mobility needs.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
CNTEAPXDFFLKEFF
Date   Source Headline
24th Jun 20244:48 pmRNSForm 8.3 - Crimson Tide Plc
24th Jun 202411:55 amRNSForm 8.5 (EPT/RI)
21st Jun 202412:45 pmRNSOffer update and possible cash offer
20th Jun 20241:38 pmRNSForm 8.3 - Crimson Tide PLC
18th Jun 20245:08 pmRNSForm 8.3 - Crimson Tide Plc
18th Jun 20244:24 pmRNSForm 8.3 - Crimson Tide Plc
18th Jun 20243:00 pmRNSForm 8.3 - Crimson Tide PLC
17th Jun 202411:55 amRNSForm 8.5 (EPT/RI) - Crimson Tide PLC
14th Jun 20246:11 pmRNSForm 8.3 - Crimson Tide PLC
14th Jun 20242:17 pmRNSForm 8.3 - CRIMSON TIDE PLC
14th Jun 20241:10 pmRNSForm 8.3 - Crimson Tide PLC
13th Jun 20247:00 amRNSForm 8 (OPD) - Crimson Tide plc
12th Jun 20245:20 pmRNSForm 8.3 - Crimson Tide PLC
11th Jun 20246:15 pmRNSForm 8.3 - Checkit plc - Amendment
11th Jun 20246:14 pmRNSForm 8.3 - Crimson Tide plc - Amendment
6th Jun 202412:22 pmRNSForm 8.3 - CRIMSON TIDE PLC
5th Jun 20245:07 pmRNSForm 8.3 - Crimson Tide PLC
5th Jun 20243:26 pmGNWForm 8.3 - [CRIMSON TIDE PLC - Opening Disclosure - 04 06 2024] - (CGWL)
5th Jun 20243:09 pmGNWForm 8.3 - Crimson Tide Plc
5th Jun 20241:48 pmGNWForm 8.3 - Crimson Tide plc
5th Jun 202410:46 amRNSForm 8.5 (EPT/NON-RI) - Crimson Tide PLC
5th Jun 202410:20 amRNSResponse to Possible Offer Announcement
4th Jun 20245:06 pmRNSRule 2.9 Announcement
4th Jun 20247:00 amRNSPossible Offer for Crimson Tide plc
3rd Jun 202410:15 amRNSPosting of Annual Report and Notice of AGM
22nd May 20247:00 amRNSBoard Changes
17th Apr 202410:05 amRNSBoard Changes
17th Apr 20247:00 amRNSPreliminary Results to 31 December 2023
23rd Jan 20247:00 amRNSTrading Update
28th Nov 20237:00 amRNSTrading Update
31st Oct 202311:45 amRNSResult of GM, Share Consolidation & TVR
10th Oct 20237:00 amRNSContract increases and extensions
6th Oct 20237:00 amRNSFurther re: Proposed Share Consolidation
5th Oct 20237:00 amRNSProposed Share Consolidation
26th Sep 20237:00 amRNSDirector dealing
25th Sep 20237:00 amRNSInterim Results
20th Sep 20237:00 amRNSContract Win
14th Sep 20237:00 amRNSStrengthened Operating Board
20th Jun 20234:20 pmRNSResult of AGM and Statement
31st May 20237:00 amRNSBoard changes
31st May 20237:00 amRNSPosting of Annual Report and Notice of AGM
10th May 20232:10 pmRNSDirectorate Change
4th May 20237:00 amRNSContract Win and Renewals
12th Apr 20237:00 amRNSPreliminary Results
5th Apr 20237:00 amRNSContract Win
1st Mar 20237:00 amRNSNotice of Results and Investor Presentation
7th Feb 20232:00 pmRNSHolding(s) in Company
6th Feb 20233:55 pmRNSHolding(s) in Company
1st Feb 20237:00 amRNSContract Win
18th Jan 20237:00 amRNSTrading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.